1. 1) Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet, 371, 143–152 (2008).
2. 2) Koutroumpakis E, Wu BU, Bakker OJ, Dudekula A, Singh VK, Besselink MG, Yadav D, Mounzer R, van Santvoort HC, Whitcomb DC, Gooszen HG, Banks PA, Papachristou GI. Admission hematocrit and rise in blood urea nitrogen at 24 h outperform other laboratory markers in predicting persistent organ failure and pancreatic necrosis in acute pancreatitis: a post hoc analysis of three large prospective databases. Am. J. Gastroenterol., 110, 1707–1716 (2015).
3. 3) Lagoo JY, D’Souza MC, Kartha A, Kutappa AM. Role of Ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: a retrospective analysis. J. Crit. Care, 45, 27–32 (2018).
4. 4) Zhang X, An R, Tian H, Zhao J. Increased risk of pancreatic cancer after acute pancreatitis: a meta-analysis of prospective cohort studies. Clin. Res. Hepatol. Gastroenterol., 43, 39–41 (2018).
5. 5) Habtezion A, Gukovskaya AS, Pandol SJ. Acute pancreatitis: a multifaceted set of organelle and cellular interactions. Gastroenterology, 156, 1941–1950 (2019).